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Endothelium-dependent, Rather than Endothelium-independent
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ABSTRACT
Parathyroid hormone (PTH) is a potent vasodilator, causing systemic hypotension. Previous investigations
concluded that vasodilation to PTH in a variety of vascular beds occurs via inhibition of L-type calcium
channels in smooth muscle cells. Further, removal of the endothelium in aortic strips and tail arteries did
not inhibit relaxation to PTH, suggesting that vasodilation in these vessels does not require nitric oxide
(NO) or vascular endothelial cells (Pang et al., 1985; Nickols 1987; Nickols et al., 1986; Crass et al., 1988).
We have previously shown that PTH 1-84 augments vasodilation to ~52% of maximum diameter in the
femoral principal nutrient artery (PNA; the primary conduit for blood flow to long bones). Further,
vasodilation was nearly obliterated with blockade of NO production with the endothelial nitric oxide
synthase inhibitor L-NAME, suggesting that vasodilation in the bone vasculature occurs exclusively via
NO-mediated signaling. Thus, to confirm these findings, the purpose of this study was to determine
whether vasodilation to PTH 1-84 occurs in the absence of endothelial cells. METHODS: Right femoral
PNAs were dissected from 4 month-old male Wistar rats (453 g; n=6), denuded (i.e., removed of the
endothelial cells) and cannulated on glass micropipettes. PNAs were considered adequately denuded if
they dilated ≤ 20 µm to a bolus dose of acetylcholine (5x10-5 M). Vasodilation to PTH 1-84 (10-13 – 10-8 M)
was assessed in the presence of 1) PSS buffer, 2) PSS buffer with L-NAME, and 3) PSS buffer with LNAME + indomethacin (Indo; a cyclooxygenase inhibitor). To ensure that the smooth muscle cells were
not damaged during endothelial cell removal, endothelium-independent vasodilation to sodium
nitroprusside (SNP; 10-10 – 10-4) was determined. RESULTS: Vasodilation to cumulative doses of PTH 1-84
peaked at 5% of maximum diameter. Inhibition of NO production with L-NAME completely inhibited
vasodilation and caused a slight vasoconstriction, while combined inhibition with L-NAME + Indo did not
constrict the femoral PNA; however, neither response differed from the PTH 1-84 response. Vasodilation
to SNP rose to 69% of maximal diameter, indicating that smooth muscle cell responsiveness was not
altered with endothelial denudation. DISCUSSION: These preliminary data support our contention that
vasodilation of the bone resistance vasculature occurs via endothelium-dependent, rather than
endothelium-independent signaling pathways. This novel finding suggests that, contrary to vasodilator
mechanisms in blood vessels from other tissue beds, bone blood vessels require the vascular endothelial
cell lining for vasodilation to PTH 1-84.
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